TY - JOUR
T1 - Imaging in patients with cardiovascular implantable electronic devices
T2 - part 2-imaging after device implantation. A clinical consensus statement of the European Association of Cardiovascular Imaging (EACVI) and the European Heart Rhythm Association (EHRA) of the ESC
AU - Stankovic, Ivan
AU - Voigt, Jens-Uwe
AU - Burri, Haran
AU - Muraru, Denisa
AU - Sade, L Elif
AU - Haugaa, Kristina Hermann
AU - Lumens, Joost
AU - Biffi, Mauro
AU - Dacher, Jean-Nicolas
AU - Marsan, Nina Ajmone
AU - Bakelants, Elise
AU - Manisty, Charlotte
AU - Dweck, Marc R
AU - Smiseth, Otto A
AU - Donal, Erwan
PY - 2024/1/1
Y1 - 2024/1/1
N2 - Cardiac implantable electronic devices (CIEDs) improve quality of life and prolong survival, but there are additional considerations for cardiovascular imaging after implantation—both for standard indications and for diagnosing and guiding management of device-related complications. This clinical consensus statement (part 2) from the European Association of Cardiovascular Imaging, in collaboration with the European Heart Rhythm Association, provides comprehensive, up-to-date, and evidence-based guidance to cardiologists, cardiac imagers, and pacing specialists regarding the use of imaging in patients after implantation of conventional pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy (CRT) devices. The document summarizes the existing evidence regarding the role and optimal use of various cardiac imaging modalities in patients with suspected CIED-related complications and also discusses CRT optimization, the safety of magnetic resonance imaging in CIED carriers, and describes the role of chest radiography in assessing CIED type, position, and complications. The role of imaging before and during CIED implantation is discussed in a companion document (part 1).
AB - Cardiac implantable electronic devices (CIEDs) improve quality of life and prolong survival, but there are additional considerations for cardiovascular imaging after implantation—both for standard indications and for diagnosing and guiding management of device-related complications. This clinical consensus statement (part 2) from the European Association of Cardiovascular Imaging, in collaboration with the European Heart Rhythm Association, provides comprehensive, up-to-date, and evidence-based guidance to cardiologists, cardiac imagers, and pacing specialists regarding the use of imaging in patients after implantation of conventional pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy (CRT) devices. The document summarizes the existing evidence regarding the role and optimal use of various cardiac imaging modalities in patients with suspected CIED-related complications and also discusses CRT optimization, the safety of magnetic resonance imaging in CIED carriers, and describes the role of chest radiography in assessing CIED type, position, and complications. The role of imaging before and during CIED implantation is discussed in a companion document (part 1).
KW - cardiac resynchronization therapy
KW - cardiovascular implantable electronic devices
KW - complications
KW - defibrillator
KW - multimodality imaging
KW - pacemaker
U2 - 10.1093/ehjci/jead273
DO - 10.1093/ehjci/jead273
M3 - Article
SN - 2047-2404
VL - 25
SP - E33-E54
JO - European Heart Journal Cardiovascular Imaging
JF - European Heart Journal Cardiovascular Imaging
IS - 1
M1 - jead273
ER -